An interventional study of Platelet rich fibrin and Control Group: collagen matrices or oxidized cellulose membrane in Palatal Donor Site Wound Healing, Platelet Rich Fibrin and Sleep Quality, sponsored by 59th Medical Wing. Completed at 1 site in United States. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by 59th Medical Wing · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 907 studies in Sleep Initiation and Maintenance Disorders with a site in United States — 149 open to participants now, 186 under way, 5 of them phase 3. Sleep Initiation and Maintenance Disorders · United States.
Among the 907 studies in Sleep Initiation and Maintenance Disorders with a site in United States, this one is the 353rd largest by enrollment of the 858 interventional ones that give a count, is one of 61 that started in 2024, is one of 580 with no phase, and was the 871st registered.
2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.
Browse Sleep Initiation and Maintenance Disorders studies →149 of the 907 studies in Sleep Initiation and Maintenance Disorders with a site in United States are open now. Recruiting first, the newest first:
Olly, PBC · Sites in United States
Ages 4–16 · Healthy volunteers
Indiana University · Sites in United States
Ages 18+ · Healthy volunteers
Spectrum Clinical Research, LLC · Sites in United States
Ages 45–65 · Women only
Florida State University · Sites in United States
Ages 6–13 · Healthy volunteers
University of Pittsburgh · Sites in United States
Ages 65+ · Women only
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.
This study: 18 Years to 99 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
907 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 40 · Phase 2 103 · Phase 3 77 · Phase 4 78
First in 1997; this study’s year is marked. 61 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 78 is above the median of 68 across 2,363 interventional studies indexed under Sleep Initiation and Maintenance Disorders.
Median enrollment 60 across the 858 interventional studies, 68 across the 49 observational. Of the 661 that completed or were terminated, 243 (37%) have results posted.
This tab as a report to print or save as PDF → With an account.
187 of 907 have an industry lead sponsor. The 10 most frequent:
59th Medical Wing is the lead sponsor of 23 studies on the registry; 2 are open to participants now.
59th Medical Wing has 1 study filed under Sleep Initiation and Maintenance Disorders — fewer than ten, so there is no comparison to draw.
80 of the studies in Sleep Initiation and Maintenance Disorders with a site in United States that are under way reach primary completion within a year, 4 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06568367Phase 3Axsome Therapeutics, Inc.Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN) | 2026-12 |
| NCT06655883Phase 3Merck Sharp & Dohme LLCA Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098) | 2027-06-24 |
| NCT07336277Phase 3Emory UniversitySleep Quality and the Efficacy of a Multimodal Sleep Pathway in Hospitalized Orthopedic Trauma Patients | 2027-07 |
| NCT06953869Phase 3Vanda PharmaceuticalsEvaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia | 2027-11 |
| NCT04278404Duke UniversityPharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) | 2026-11 |
Add all 80 to your calendar (.ics) → With an account.
Among the 907 studies in Sleep Initiation and Maintenance Disorders with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial (2-arm) is to determine if the application of platelet rich fibrin (PRF) to palatal donor sites influence patients quality of life, sleep efficiency, and healing following mucogingival surgery. All patients were enrolled in the Air Force Post Graduate Dental School periodontics program and each patient required mucogingival surgery. The main question[s] it aims to answer [is/are]:
Participants will be randomly assigned to either receiving PRF or a commercially available product on the day of surgery. A survey response will be conducted at five time points (pre-operative, 24-hours, 72 hours, 1 week, 2 week) to obtain a quality of life metric. Sleep data was collected via a wearable device one week pre-surgical intervention and two weeks postoperatively. Finally, a clinical healing index was performed at 1 and 2 weeks post-operatively to obtain a healing score.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The test group had approximately 40 ml of whole venous blood collected from their antecubital fossa (R/L) prior to surgical start for the fabrication of PRF. Tubes were placed immediately into a US Food and Drug Administration (FDA)-approved horizontal centrifuge (Horizon 6 Drucker Diagnostics; Port Matilda, PA), and spun at 2300 rpm (700 g) for 16 min. After the centrifugation was complete, the PRF matrices were compressed into membranes. At the completion of surgery, PRF membranes (1-3) were placed at the harvest site. A palatal stent was used to secure the wound dressings via compression only, and no sutures were utilized for fixation at the harvest sites.
Procedure: Platelet rich fibrin
The control group had a commercially available wound dressing placed at the harvest site. A palatal stent was used to secure the wound dressing via compression only, and no sutures were utilized for fixation at the harvest sites.
Other: Control Group: collagen matrices or oxidized cellulose membrane
The test group had approximately 40 ml of whole venous blood collected from their antecubital fossa (R/L) prior to surgical start for the fabrication of PRF. Tubes were placed immediately into a US Food and Drug Administration (FDA)-approved horizontal centrifuge (Horizon 6 Drucker Diagnostics; Port Matilda, PA), and spun at 2300 rpm (700 g) for 16 min. After the centrifugation was complete, the PRF matrices were compressed into membranes. At the completion of surgery, PRF membranes (1-3) were used as a wound dressing at the harvest site. A palatal stent was used to secure the PRF via compression only, and no sutures were utilized for fixation at the harvest sites. Patients were instructed not to remove the palatal stent for 48 hours.
On the day of surgery, subjects randomized into the control group had a commercially available product of the surgeons choice (collagen matrices or oxidized cellulose membrane) placed at the palatal donor site. The matrix was compressed with a palatal stent and subjects were instructed to not remove the stent for 48 hours.
Quality of Life: Oral Health Impact Profile -14 (OHIP-14). Summative Scores Were Utilized as a Quality of Life Metric at Five Different Time Points. These Scores Were Compared Between the Test and Control Group.
OHIP-14 Questionnaire: includes 7 patient domains (2 questions for each domain). 1. Functional Limitation 2. Physical pain 3. Psychological discomfort 4. Physical disability 5. Psychological disability 6. Social disability 7. Handicap Patients are asked to answer questions on the 5-point Likert scale below. The additive total of the 14 questions is the total OHIP-14 score. Lower scores correlate to higher Quality of Life (QoL). A mixed model regression was run with a PRF wound dressing as the independent variable. Therefore, all scores were combined and time was factored in the mixed modeled regression. This is why only one statistical analysis score is noted. Likert Scale answer choices: Very Often(4), Fairly Often(3), Occasionally(2), Hardly Ever (1), Never(0). Range: 0-54. High QoL (OHIP Score: \< 19), Moderate QoL (OHIP-14 Score: 19-37), Low QoL (OHIP-14 Score 38-56). OHIP-14 was completed pre-surgically, 24 hours, 72 hours, 1 week, and 2 weeks.
Time frame: Pre-surgical survey to 2 weeks following surgical intervention.
Sleep Quality: Sleep Quality Index (SQI) Was Obtained From Wearable Device Which Serves as a Summary Index of the Cardiopulmonary Coupling Biomarkers of Sleep Quality, Sleep Stability, Fragmentation, and Periodicity.
A sleep monitoring device was issued to patients following informed consent (SleepImage® Ring 2019, SleepImage, Denver, CO). The sleep monitoring app will be downloaded on subjects' phones and each subject will be briefed on the function of the application. Subjects will be instructed to wear the device nightly throughout the study. SQI (sleep quality index) scale is 1-100. Higher numbers are consistent with a higher quality sleep. Average baseline (pre-surgery) SQI was recorded. 24 hour, 72 hour, average sleep quality in week 1, and average sleep quality in week 2. A mixed model regression was run with a PRF wound dressing as the independent variable. Therefore, all scores were combined and time was factored in the mixed modeled regression. This is why only one statistical analysis score is noted for sleep analysis.
Time frame: 1 week pre-surgery to 2-weeks following surgical intervention.
Pain: a Numeric Pain Scale (0-10) Was Used to Document Site Specific Palatal Harvest Pain.
The Qualtrics survey tool sent out automated emails at 24 hours, 72 hours, 1-week and 2-week time points from the time of pre-surgery survey completion asking a question regarding pain at the palatal harvest site. Survey question: What is your pain at the palatal harvest site on a scale of 0-10? (NRS-11). 0 (minimum) indicates no pain. 10 (maximum) is extreme pain. A mixed model regression was run with a PRF wound dressing as the independent variable. Therefore, all scores were combined and time was factored in the mixed modeled regression. This is why only one statistical analysis score is noted.
Time frame: From pre-surgery survey, final survey was 2 weeks post surgical intervention.
Analgesic Consumption: a (Yes/No) Survey Question Was Asked Regarding Analgesic Consumption. If the Patient Answered "Yes" to Using Medications to Relieve Pain, They Were Added to the Number of Participants Who Used Medication at That Time Point.
The Qualtrics survey tool sent out automated emails at 24 hours, 72 hours, 1-week and 2-week time points from the time of pre-surgery survey completion. Survey question: Did you take any mediation today to relieve pain or swelling? (yes/no). This was measured by number of participants who took medication to relieve pain and swelling. If a participant answered "Yes" to the survey question at the specific time point, they were counted as having taking medications to relieve pain or swelling. If they answered "No" they were note included. Amount of analgesic use was not documented. Simply a dichotomous "Yes" or "No". A mixed model regression was run with a PRF wound dressing as the independent variable. Therefore, all scores were combined and time was factored in the mixed modeled regression. This is why only one statistical analysis score is noted.
Time frame: From pre-surgery survey to two weeks post surgical intervention.
Physiologic Healing at Palatal Donor Site: 5-point Healing Scale Landry et al Scale
At the follow-up appointments the surgeons were asked to document the presence of suppuration or bleeding at the palatal wound site. A standardized photograph was then taken with the following parameters (F-stop: 29, ISO: 200, Shutter Speed: 125). Two calibrated, blinded examiners then assessed the palatal wound based on the Landry et al palatal healing index. Each examiner provided a score (1-5). Lower scores = poorer healing. Higher scores = advanced healing. If the scores were not in concordance, a third calibrated blind examiner assessed the palatal wound based on the Landry et al palatal healing index. This served as the "tie-breaker" score. For example, if examiner #1 scored a (1), and examiner #2 scored a (2), the palate was examined by the third examiner. If examiner #3 scored a (2) then the patient received a score of (2). If the third examiner scored a different number then both examiners, then the highest and lowest score were removed and the middle score was recorded.
Time frame: Healing was assessed at 1-week and 2-weeks post surgical intervention.
Patients undergoing mucogingival surgery at the United States Air Force postgraduate periodontics program were enrolled. Indications for treatment included patients with \< 2 mm of keratinized tissue (KT), gingival recession, esthetic concerns, peri-implant augmentation, and tissue phenotype conversion. Subjects were screened from March 6, 2024, to February 17, 2025.
| Milestone | Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing | Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane |
|---|---|---|
| Started | 39 | 39 |
| Completed | 39 | 39 |
| Not completed | 0 | 0 |
OHIP-14 Questionnaire: includes 7 patient domains (2 questions for each domain). 1. Functional Limitation 2. Physical pain 3. Psychological discomfort 4. Physical disability 5. Psychological disability 6. Social disability 7. Handicap Patients are asked to answer questions on the 5-point Likert scale below. The additive total of the 14 questions is the total OHIP-14 score. Lower scores correlate to higher Quality of Life (QoL). A mixed model regression was run with a PRF wound dressing as the independent variable. Therefore, all scores were combined and time was factored in the mixed modeled regression. This is why only one statistical analysis score is noted. Likert Scale answer choices: Very Often(4), Fairly Often(3), Occasionally(2), Hardly Ever (1), Never(0). Range: 0-54. High QoL (OHIP Score: \< 19), Moderate QoL (OHIP-14 Score: 19-37), Low QoL (OHIP-14 Score 38-56). OHIP-14 was completed pre-surgically, 24 hours, 72 hours, 1 week, and 2 weeks.
| OHIP-14 Scores | Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing | Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane |
|---|---|---|
| Pre-Surgery | 8 (2 to 16) | 7 (1 to 15) |
| 24 Hours | 17 (12 to 24) | 18 (13 to 27) |
| 72 Hours | 17 (8 to 23) | 19 (9 to 27) |
| 1 week | 13 (8 to 21) | 18 (10 to 28) |
| 2 weeks | 8 (4 to 14) | 12 (6 to 21) |
A sleep monitoring device was issued to patients following informed consent (SleepImage® Ring 2019, SleepImage, Denver, CO). The sleep monitoring app will be downloaded on subjects' phones and each subject will be briefed on the function of the application. Subjects will be instructed to wear the device nightly throughout the study. SQI (sleep quality index) scale is 1-100. Higher numbers are consistent with a higher quality sleep. Average baseline (pre-surgery) SQI was recorded. 24 hour, 72 hour, average sleep quality in week 1, and average sleep quality in week 2. A mixed model regression was run with a PRF wound dressing as the independent variable. Therefore, all scores were combined and time was factored in the mixed modeled regression. This is why only one statistical analysis score is noted for sleep analysis.
| Sleep Quality Index (SQI) | Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing | Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane |
|---|---|---|
| Pre-Surgery SQI | 45 (34 to 58) | 46 (30 to 60) |
| 24 hour SQI | 38 (29 to 65) | 35 (28 to 53) |
| 72 hour SQI | 40 (31 to 63) | 39 (28 to 53) |
| 1 week SQI | 43 (32 to 55) | 40 (31 to 58) |
| 2 week SQI | 46 (34 to 54) | 42 (31 to 55) |
The Qualtrics survey tool sent out automated emails at 24 hours, 72 hours, 1-week and 2-week time points from the time of pre-surgery survey completion asking a question regarding pain at the palatal harvest site. Survey question: What is your pain at the palatal harvest site on a scale of 0-10? (NRS-11). 0 (minimum) indicates no pain. 10 (maximum) is extreme pain. A mixed model regression was run with a PRF wound dressing as the independent variable. Therefore, all scores were combined and time was factored in the mixed modeled regression. This is why only one statistical analysis score is noted.
| Scores on a scale | Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing | Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane |
|---|---|---|
| Pre-Surgical Harvest Site Pain | 0 (0 to 0) | 0 (0 to 0) |
| 24-Hour | 2 (0 to 4) | 2 (1 to 3) |
| 72 hour | 2 (1 to 3) | 2.5 (1 to 4) |
| 1 week | 2 (0 to 3) | 3 (1 to 4) |
| 2 week | 0 (0 to 1) | 1 (0 to 2) |
The Qualtrics survey tool sent out automated emails at 24 hours, 72 hours, 1-week and 2-week time points from the time of pre-surgery survey completion. Survey question: Did you take any mediation today to relieve pain or swelling? (yes/no). This was measured by number of participants who took medication to relieve pain and swelling. If a participant answered "Yes" to the survey question at the specific time point, they were counted as having taking medications to relieve pain or swelling. If they answered "No" they were note included. Amount of analgesic use was not documented. Simply a dichotomous "Yes" or "No". A mixed model regression was run with a PRF wound dressing as the independent variable. Therefore, all scores were combined and time was factored in the mixed modeled regression. This is why only one statistical analysis score is noted.
| Participants | Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing | Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane |
|---|---|---|
| Pre-Surgery | 2 (0.355 to 0.954) | 2 (1.734 to 12.358) |
| 24 hours | 33 | 32 |
| 72 hours | 30 | 30 |
| 1 week | 19 | 28 |
| 2 week | 2 | 6 |
At the follow-up appointments the surgeons were asked to document the presence of suppuration or bleeding at the palatal wound site. A standardized photograph was then taken with the following parameters (F-stop: 29, ISO: 200, Shutter Speed: 125). Two calibrated, blinded examiners then assessed the palatal wound based on the Landry et al palatal healing index. Each examiner provided a score (1-5). Lower scores = poorer healing. Higher scores = advanced healing. If the scores were not in concordance, a third calibrated blind examiner assessed the palatal wound based on the Landry et al palatal healing index. This served as the "tie-breaker" score. For example, if examiner #1 scored a (1), and examiner #2 scored a (2), the palate was examined by the third examiner. If examiner #3 scored a (2) then the patient received a score of (2). If the third examiner scored a different number then both examiners, then the highest and lowest score were removed and the middle score was recorded.
| Score on a scale | Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing | Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane |
|---|---|---|
| 1 week | 3 (2 to 3) | 2 (2 to 3) |
| 2 week | 4 (3 to 4) | 3 (3 to 4) |
Collected over From enrollment to two weeks post surgical intervention.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing | 0/39 (0%) | 0/39 (0%) | 0/39 (0%) |
| Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane | 0/39 (0%) | 0/39 (0%) | 0/39 (0%) |
| Age, Continuous(Years) | Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing | Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane | Total |
|---|---|---|---|
| Median | 39 (30 to 59) | 47 (35 to 64) | 45 (33 to 61) |
| Sex: Female, Male(Participants) | Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing | Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane | Total |
|---|---|---|---|
| Female | 19 | 18 | 37 |
| Male | 20 | 21 | 41 |
| Race and Ethnicity Not Collected(Participants) | Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing | Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane | Total |
|---|---|---|---|
| Count of participants | — | — | 0 |
| Length of Procedure(Minutes) | Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing | Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane | Total |
|---|---|---|---|
| Median | 150 (105 to 180) | 150 (120 to 180) | 150 (105 to 180) |
| Type of Procedure(Participants) | Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing | Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane | Total |
|---|---|---|---|
| Coronally Advanced Flap (CAF) | 8 | 6 | 14 |
| Free Soft Tissue Autograft (FSTA) | 15 | 13 | 28 |
| Implant + connective tissue graft | 5 | 7 | 12 |
| Implant + FSTA | 0 | 1 | 1 |
| Tunneling | 6 | 6 | 12 |
| Vestibular Incision Subperiosteal Tunnel (VISTA) | 5 | 6 | 11 |
| Graft Size(Participants) | Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing | Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane | Total |
|---|---|---|---|
| Large Graft Size | 12 | 20 | 32 |
| Medium Graft Size | 15 | 8 | 23 |
| Small Graft Size | 12 | 11 | 23 |
| Type of Sedation(Participants) | Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing | Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane | Total |
|---|---|---|---|
| IV sedation | 25 | 26 | 51 |
| Local anesthesia alone | 8 | 6 | 14 |
| Nitrous Oxide | 3 | 4 | 7 |
| Oral + IV sedation | 3 | 3 | 6 |
| Use of intravenous steroids(Participants) | Test Group: Horizontally Centrifuged PRF Membranes Used as Palatal Dressing | Control Group: Collagen Wound Dressing or Oxidized Cellulose Membrane | Total |
|---|---|---|---|
| Participants that received IV dexamethasone | 28 | 29 | 57 |
| Participants that did not receive IV dexamethasone | 11 | 10 | 21 |
1 further baseline measures are reported on the registry.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — All de-identified participant date sets are to be shared upon request.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code
Time frame: Beginning 3 months and ending 3 years after the publication of results.
Access criteria: The Air Force Post Graduate Dental School will be in charge of allowing access to IPD upon request.
Ran from May 2024 to primary completion in Mar 2025, 9 months.
Results were first posted in Oct 2026, 1 year 7 months after primary completion.
Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's 9 months is below that.
Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sleep Initiation and Maintenance Disorders →
59th Medical Wing